Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 07/29 09:52:08 am
75.025 EUR   -1.66%
08:56aDJSanofi Profit Down as Diabetes Drug Sales Slip
07:45aDJSANOFI : Profit Down as Diabetes Drug Sales Slip
07:31a SANOFI : Announces Q2 2016 Results
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals27,72082.1%29,79986.3% +7.5%
Vaccines3,97411.8%4,74313.7% +19.35%
Animal Health2,0766.1%---
Sales per Regions
20142015Delta
EUR (in Million)%EUR (in Million)%
Other Countries11,45333.9%11,83034.2% +3.29%
United States11,33933.6%12,24635.5% +8%
Europe7,93223.5%7,61322% -4.02%
France2,4747.3%2,2486.5% -9.14%
North America572.001.7%605.001.8% +5.77%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer & Director
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Group Chief Medical Officer & Executive VP
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,305,696,759 1,150,028,635 88.1% 3,956,708 0.3% 88.1%
Shareholders
NameEquities%
L'Oréal SA 118,227,307 9.19%
Norges Bank Investment Management 26,541,076 2.06%
Dodge & Cox 25,166,652 1.96%
The Vanguard Group, Inc. 23,019,487 1.79%
Berkshire Hathaway, Inc. (Investment Management) 22,169,930 1.72%
Amundi Asset Management SA (Investment Management) 19,430,202 1.51%
Plan d'Epargne Entreprise Sanofi Synthelabo 16,697,049 1.30%
Lyxor International Asset Management SAS 14,134,914 1.10%
BlackRock Fund Advisors 13,586,898 1.06%
Natixis Asset Management SA 12,973,880 1.01%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,418,39622.7%8,178,406,435 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%913,999,657 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%569,140,565 USD
Sanofi (SAN) 3,956,7080.31%329,326,184 USD
Zentiva SA (ROSCD) 312,341,64974.9%136,577,633 USD
Myokardia Inc (MYOK) 3,218,89911.9%39,914,348 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%27,232,572 USD
Immune Design Corp (IMDZ) 917,4294.55%7,486,221 USD
Proteome Sciences plc (PRM) 38,0000.017%7,112 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 500.0001%1,011 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI-2.42%108 940
JOHNSON & JOHNSON21.16%342 345
PFIZER INC.13.60%222 398
ROCHE HOLDING LTD.-9.99%215 597
NOVARTIS AG-5.30%214 061
MERCK & CO., INC.10.62%161 736
BRISTOL-MYERS SQUIBB C..8.53%124 630
NOVO NORDISK A/S-5.53%113 265
GLAXOSMITHKLINE PLC23.78%109 108
ALLERGAN PLC-18.22%101 089
ELI LILLY AND CO-1.58%91 596
BAYER AG-18.56%86 404
ASTRAZENECA PLC1.59%84 042
ABBOTT LABORATORIES-1.02%65 304
SHIRE PLC2.55%57 253
TEVA PHARMACEUTICAL IN..-17.76%50 200
ASTELLAS PHARMA INC-1.37%35 223
TAKEDA PHARMACEUTICAL ..-24.45%34 576
MYLAN NV-13.59%23 751
CHUGAI PHARMACEUTICAL ..-7.31%20 877
SHIONOGI & CO LTD-0.98%18 232
Sector Pharmaceuticals - NEC
Sanofi : Connections
International Federation of Pharmaceutical Manufacturers A
Aventis Foundation
Montres CORUM Sàrl
Fondation Lacoste
Maremma SASU
Institute of Medicine
Alliance Automotive Group SAS
Pharmaceutical Research & Manufacturers of America
Financières SASA
Academie des Sports
Piasa SA
Académie Nationale de Médecine
MedImmune LLC
Madrigall SA
Bordeaux University Foundation
Fondation C.Génial
L'Oréal Corporate Foundation
Council on Foreign Relations, Inc.
Académie des Sciences et Technologies
Sanofi-Aventis Europe SAS
Piasa Holding SAS
Sanofi-Aventis Participations SA
National Academy of Engineering
The Johns Hopkins University
Weinberg Capital Partners SAS
Sanofi-Aventis U.S. LLC
National Committee on United States-China Relations, Inc.
Financière Piasa SAS
Sanofi Pasteur Holding SA
Fondation de France
Sanofi Pasteur Holding & Merial Ltd.
Pres héSam
Fondation pour l’Université de Lyon
The Children's Aid Society, Inc.
Académie des Technologies
Research!America
Academie de l'air et de l'espace
King Abdullah University of Science & Technology
Philipps University of Marburg
Warp Drive Bio LLC
Ruprecht-Karls-Universität Heidelberg
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem